Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
jRCT2071210043Phase 1Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing TS-172 with Placebo (2 arms). Primary endpoints: Safety of TS-172, Pharmacokinetics of TS-172 and 1 more. Started Aug 2021; status: completed.
02
Drugs
TS-172
Beyond the preview
Go deeper on jRCT2071210043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210043.